Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Discover which cashback cards are fee-free and how they can benefit your finances. Make informed choices!
26,758 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
A listener on a popular financial show asks whether a HELOC could erase credit card debt and fund a new car. The host...
Glenn Kelman has joined Greylock Partners as an executive in residence, months after stepping down from Redfin and fo...
Apple stock just dropped as memory costs surge and device pricing shifts bite into margins. Traders weigh supply-chai...
A widow spent $1.1 million on cruise-ship art in the years after her husband’s death, shining a light on grief-driven...
Micron Technology has unleashed a dramatic first half, but the market now eyes a cautious microns stock price predict...
A major enforcement push in Louisiana led to 21 new arrests in a Medicaid fraud crackdown. This article explains what...
Tesla's delivery report just signaled a demand rebound. In this analysis, we uncover three takeaways investors can us...
A new poll finds a prevailing mood that founders would be disappointed by modern democracy. This sentiment is shaping...
In 2025, Pelosi outpaced the S&P 500 as Trump pressed a high-volume, fast-paced trading strategy across multiple acco...
Public hearings and local politics are slowing housing supply, hitting renters and buyers with higher costs. This rep...
Eli Lilly's blockbuster first quarter puts the spotlight on a possible stock split as its high-priced shares approach...